CFTR and cystic fibrosis: Atropine also reduced the response to HTS treatment in preparations incubated with the CFTR blocker CFTRinh172, but had no effect on ITS-treated preparations, suggesting a role for cholinergic signaling in HTS-triggered ASL secretion in both CF and non-CF airways.